Burant named new director of the Taubman Institute

July 5, 2017  //  FOUND IN: Strategy & Leadership

Charles Burant, M.D., Ph.D., has been selected as the new director of the A. Alfred Taubman Medical Research Institute. His new role took effect on July 1.  Dr. Burant succeeds distinguished neurology professor Eva Feldman, M.D., Ph.D., who served as its founding director. 

Burant holds the Robert C. and Veronica Atkins Professor of Metabolism endowed chair, and is professor of internal medicine, section of metabolism, endocrinology and diabetes. He is also appointed as a professor in molecular and integrative physiology in the U-M Medical School, as well as in the Schools of Public Health and Kinesiology.

Burant developed and is director of the Michigan Metabolomics and Obesity Center, which provides infrastructure and expertise for researchers across the country to perform basic and clinical research in metabolism, obesity and diabetes. His personal research program studies how individual differences in metabolism affect longevity and risk for metabolic diseases, spanning the range from basic to translational to clinical research.

Burant earned his M.D. and Ph.D. in molecular and cellular biology from the Medical University of South Carolina. He then completed a residency at the University of California, San Francisco, and a fellowship in endocrinology at the University of Chicago before joining the U-M faculty in 1999.

In his new role, Burant will be instrumental in implementing the strategies and priorities recently identified as the Taubman Institute’s future strategic direction. His broad expertise, experience in creating collaborative research teams and commitment to discovery and innovation will help propel the Taubman Institute to new heights in research discovery to advance the understanding of health and disease, leading to new medical treatments.

Please welcome and support Dr. Burant in his new role as director of the Taubman Institute!